These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3165474)

  • 41. [Distribution of cefotiam dihydrochloride to the bloodless lung].
    Fujimoto Y; Monden Y; Nakahara K; Nanjo S; Ohno K; Fujii Y; Hashimoto J; Kitagawa Y; Miyoshi S; Maeda H
    Jpn J Antibiot; 1985 Jan; 38(1):155-9. PubMed ID: 3857358
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Absorption of ceftizoxime from peritoneal dialysate and its pharmacokinetics in chronic kidney failure patients].
    Gao S; Li P; Liu GL; Wang SX; Chui RL; Yang JP
    Zhongguo Yao Li Xue Bao; 1992 Jul; 13(4):377-80. PubMed ID: 1456067
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].
    Mounier M; Benevent D; Denis F
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):542-4. PubMed ID: 3911152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Concentration of cefotiam in the human bone marrow fluid and bone tissue (author's transl)].
    Kikuchi S; Hoshika I; Matsui T; Hasue M
    Jpn J Antibiot; 1982 Apr; 35(4):1053-6. PubMed ID: 6285022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pharmacokinetic and clinical studies of cefotiam in the perinatal period].
    Yamamoto T; Yasuda J; Kanao M; Okada H
    Jpn J Antibiot; 1986 Sep; 39(9):2525-33. PubMed ID: 3467093
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The studies on distributions of cefsulodin and cefotiam to human aqueous humor and cornea].
    Momose A; Kasahara A; Fugono T; Mizuta E
    Jpn J Antibiot; 1982 Dec; 35(12):2879-93. PubMed ID: 6304364
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Tissue distribution of beta-lactam antibiotics, cefotiam and cefmenoxime in the lungs of sheep].
    Hirai K; Kobayashi T; Kobayashi H; Shibamoto T; Kubo K; Kitazawa K; Yagi H; Kusama S
    Jpn J Antibiot; 1988 Jan; 41(1):48-52. PubMed ID: 3163382
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Distribution of an antibiotic (cefotiam) to the breast tissue].
    Kobayashi T; Yayoi E; Naoi M; Mori T
    Jpn J Antibiot; 1984 Sep; 37(9):1647-51. PubMed ID: 6096583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum and dialyzate concentrations of intraperitoneal cephalothin in patients undergoing continuous ambulatory peritoneal dialysis.
    Münch R; Steurer J; Lüthy R; Siegenthaler W; Kuhlmann U
    Clin Nephrol; 1983 Jul; 20(1):40-3. PubMed ID: 6883818
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of cefotiam in the exudate from wounds of patients with breast cancer operated upon for radical mastectomy.
    Mizuta E; Kaneko Y; Nishindai H; Yoshimoto M; Nakanishi Y; Hashimoto I; Sawada Y; Nakamura T; Mikami J
    Jpn J Antibiot; 1986 Jan; 39(1):109-15. PubMed ID: 3457961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of aztreonam administered i.p. in continuous ambulatory peritoneal dialysis (CAPD) patients.
    Nikolaidis P; Dombros N; Alexiou P; Balaskas E; Tourkantonis A
    Perit Dial Int; 1989; 9(1):57-9. PubMed ID: 2488183
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical study of diffusion of cefotiam into myocardial tissue].
    Hibi M; Abe T; Murase M; Tanaka M; Takeuchi E; Iyomasa Y
    Jpn J Antibiot; 1983 Oct; 36(10):2671-4. PubMed ID: 6325735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. How long can continuous ambulatory peritoneal dialysis be continued?
    Okada K; Takahashi S; Higuchi T; Kinoshita Y; Kikuchi F; Yamauchi T; Yanai M; Kuno T; Nagura Y
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):65-71. PubMed ID: 8336402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Joffe P; Olsen F; Heaf JG; Gammelgaard B; Pödenphant J
    Clin Nephrol; 1989 Sep; 32(3):133-8. PubMed ID: 2791364
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of peritonitis in kidney failure patients under continuous ambulatory peritoneal dialysis by pefloxacine. Results and pharmacokinetics].
    Denis F; Mounier M; Lagarde C; Benevent D
    Pathol Biol (Paris); 1987 May; 35(5):652-5. PubMed ID: 3302879
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trimethoprim-sulfamethoxazole pharmacokinetics during continuous ambulatory peritoneal dialysis (CAPD).
    Walker SE; Paton TW; Churchill DN; Ojo B; Manuel MA; Wright N
    Perit Dial Int; 1989; 9(1):51-5. PubMed ID: 2488182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Placental transfer of cefotiam dihydrochloride.
    Miyakawa I; Inoue H; Kuroki T; Lee HC; Azegami M; Mori N
    Antimicrob Agents Chemother; 1984 Jan; 25(1):147-8. PubMed ID: 6322677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Biliary tract infections and antibiotics concentration of cefotiam in gallbladder tissue and bile (author's transl)].
    Saito S; Yoshida M
    Jpn J Antibiot; 1982 Apr; 35(4):1057-62. PubMed ID: 6285023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis.
    Burgess ED; Blair AD
    Antimicrob Agents Chemother; 1983 Aug; 24(2):237-9. PubMed ID: 6314887
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The migration of cefotiam to cerebrospinal fluid].
    Eguchi T; Mayanagi Y; Hanamura T; Iai S; Asai A
    Jpn J Antibiot; 1983 Feb; 36(2):213-20. PubMed ID: 6304365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.